HomeEVOK ⢠NASDAQ
add
Evoke Pharma Inc
Previous close
$5.45
Day range
$5.45 - $5.81
Year range
$1.94 - $12.32
Market cap
8.51M USD
Avg Volume
4.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 3.08M | 77.48% |
Operating expense | 4.34M | 38.04% |
Net income | -1.31M | 17.32% |
Net profit margin | -42.41 | 53.41% |
Earnings per share | -0.51 | 75.00% |
EBITDA | ā | ā |
Effective tax rate | ā | ā |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.62M | 30.11% |
Total assets | 16.38M | 31.49% |
Total liabilities | 10.53M | 17.62% |
Total equity | 5.84M | ā |
Shares outstanding | 2.02M | ā |
Price to book | 1.89 | ā |
Return on assets | -19.20% | ā |
Return on capital | -28.07% | ā |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -1.31M | 17.32% |
Cash from operations | -997.51K | 61.33% |
Cash from investing | ā | ā |
Cash from financing | 25.00K | -99.67% |
Net change in cash | -972.51K | -119.59% |
Free cash flow | -702.37K | 66.83% |
About
Founded
2007
Headquarters
Website
Employees
3